Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in MLTX — MoonLake Immunotherapeutics

CIK 1603466 STAMFORD, CT
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,560,512
-$2,948,663 QoQ
Shares Held
1,158,732
-15.3% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#14
of 172 holders
Holding Since
Dec 2020
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Derivatives in MLTX

reported options exposure · as of Dec 31, 2023
CallValue
$2,475,990
CallShares
41,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. MLTX ranks #31 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in MLTX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,560,512 1,158,732
2026-03-31 $25,509,175 1,368,518
2025-12-31 $10,181,550 772,500
2025-09-30 $70,266 9,800
2025-06-30 $8,806,009 186,568
2024-12-31 $5,345,633 98,719
2023-12-31 $2,475,990 41,000
2023-03-31 $636,309 29,748
2022-09-30 $2,599,600 335,000